New Research Refutes the Concept of Iodine Allergies
|
By MedImaging International staff writers Posted on 04 Oct 2021 |

Image: A new study concludes Iodine allergy is a myth (Photo courtesy of iStockPhoto)
A new study concludes that there is no impediment to administering iodine-containing contrast agents before imaging, as there are no verified, documented cases of allergic reactions to iodine.
Researchers at First Databank (San Francisco, CA, USA), Stanson Health (Charlotte, NC, USA), and the Mayo Clinic (Rochester, MN, USA) conducted a literature review to evaluate current evidence regarding iodine allergy and iodine-containing drugs. In all, of 435 articles considered potentially appropriate for full review (plus an additional 12 articles included on the basis of references from the eligible articles), 113 could not be obtained. After exclusion of 353 articles that did not meet all inclusion criteria, the remaining 81 articles were included in the review.
The results indicated iodine has not been shown to be the allergen responsible for allergic reactions to iodinated contrast media, amiodarone, povidone-iodine, and other iodine-containing compounds, and that therefore there is a lack of evidence supporting cross-reactivity between iodine-containing compounds in those defined as iodine-allergic individuals. The study was published in the May 2021 issue of the American Journal of Health-System Pharmacy.
“We could find no documented cases from more than 70 years of research where iodine itself was responsible for patient reactions,” said lead author Nicole Wulf, PharmD, of FDB. “While these patients likely had reactions to the contrast media, iodine was most likely not responsible, nor did most of these reactions meet the definition of an allergic reaction, which requires an immune-mediated reaction such as antibody release and symptoms such as rash, swollen tongue or face, or even difficulty breathing.”
“Another unfortunate consequence of a patient's self-identified iodine allergy is that it could result in a care delay or a patient receiving unnecessary steroids before an imaging test, which could cause harm,” said senior author Joan Kapusnik-Uner, PharmD . “Healthcare providers who still ask patients about iodine or seafood allergies before an imaging study should reassess these protocols and implement a safety screen that is evidence-based. The bottom line is contrast agents help save lives, and should be used when clinically indicated and safe to do so.”
Iodine is an essential trace element for life, used as a constituent of the thyroid hormones thyroxine (T4) and triiodothyronine (T3). As humans cannot produce it, it must be consumed. As iodine levels in seafood are higher than in non-seafood items, a common myth is that seafood "allergy" results from the iodine, while in fact it an allergic reaction to the muscle protein tropomyosin. In fact, over 85% of patients with reported seafood allergies will not have an adverse reaction to iodinated contrast agents.
Related Links:
First Databank
Stanson Health
Mayo Clinic
Latest General/Advanced Imaging News
- AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
- AI-Based Tool Accelerates Detection of Kidney Cancer
- New Algorithm Dramatically Speeds Up Stroke Detection Scans
- 3D Scanning Approach Enables Ultra-Precise Brain Surgery
- AI Tool Improves Medical Imaging Process by 90%
- New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
- AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
- Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
- Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
- Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
- New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
- AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
- CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
Channels
Radiography
view channel
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read more
AI Detects Early Signs of Aging from Chest X-Rays
Chronological age does not always reflect how fast the body is truly aging, and current biological age tests often rely on DNA-based markers that may miss early organ-level decline. Detecting subtle, age-related... Read moreMRI
view channel
MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
Recovery after traumatic brain injury (TBI) varies widely, with some patients regaining full function while others are left with lasting disabilities. Prognosis is especially difficult to assess in patients... Read more
Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
Vascular dysfunction in the spinal cord contributes to multiple neurological conditions, including traumatic injuries and degenerative cervical myelopathy, where reduced blood flow can lead to progressive... Read more
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read moreUltrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read moreNuclear Medicine
view channel
PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more
Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
Aggressive cancers such as osteosarcoma and glioblastoma often resist standard therapies, thrive in hostile tumor environments, and recur despite surgery, radiation, or chemotherapy. These tumors also... Read more
New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read morePatient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more







